Evaluation of dexmedetomidine use as an adjunctive therapy in the management of alcohol withdrawal syndrome
2020 ASHP Midyear Clinical Meeting / New Orleans, Louisiana / Poster # RP-606
The objective of this medication use evaluation (MUE) was to assess the utilization and outcomes associated with dexmedetomidine in the treatment of alcohol withdrawal syndrome
Kormanyos, Zsanett PharmD; Linn, Dustin D. PharmD, BCPS, BCCCP; and Coons, Jillian PharmD, BCPS, "Evaluation of dexmedetomidine use as an adjunctive therapy in the management of alcohol withdrawal syndrome" (2020). Pharmacy. 33.